BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8079737)

  • 1. The effect of vinca alkaloids on tumour blood flow.
    Hill SA; Lonergan SJ; Denekamp J; Chaplin DJ
    Adv Exp Med Biol; 1994; 345():417-22. PubMed ID: 8079737
    [No Abstract]   [Full Text] [Related]  

  • 2. Vinca alkaloids: anti-vascular effects in a murine tumour.
    Hill SA; Lonergan SJ; Denekamp J; Chaplin DJ
    Eur J Cancer; 1993; 29A(9):1320-4. PubMed ID: 8343277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell production in tumour isografts measured using vincristine and Colcemid.
    Smith SR; Thomas DB; Riches AC
    Cell Tissue Kinet; 1974 Nov; 7(6):529-36. PubMed ID: 4434454
    [No Abstract]   [Full Text] [Related]  

  • 4. Investigations on partial synchronization in ascites tumors of different ploidy and in solid transplantable tumors.
    Lennartz KJ; Klein HO; Feaux de Lacroix W
    Recent Results Cancer Res; 1975; (52):179-86. PubMed ID: 1234998
    [No Abstract]   [Full Text] [Related]  

  • 5. Unusual potentiation by vinca alkaloids of the cytostatic and cytocidal action of methyl-3,5-diiodo-4-(4'-methoxyphenoxy) benzoate (DIME) and its nonhydrolyzable ethanone analog (DIPE) on MDA-MB-231 human mammary cancer cells.
    Kirsten E; Buki KG; Mendeleyev J; Vidair CA; Kun A; Kun E
    Int J Oncol; 1998 Jul; 13(1):49-55. PubMed ID: 9625802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on microtubules in vitro.
    Himes RH; Kersey RN; Heller-Bettinger I; Samson FE
    Cancer Res; 1976 Oct; 36(10):3798-802. PubMed ID: 954003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of vindesine, vinblastine, and vincristine on mitotic arrest and hormonal response of L1210 leukemia cells.
    Howard SM; Theologides A; Sheppard JR
    Cancer Res; 1980 Aug; 40(8 Pt 1):2695-700. PubMed ID: 6248211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxygen distribution in tumours: influence on cell proliferation and implications for tumour therapy.
    Tannock I
    Adv Exp Med Biol; 1976; 75():597-603. PubMed ID: 1015439
    [No Abstract]   [Full Text] [Related]  

  • 9. Increase of cyclic adenosine 3':5'-monophosphate concentration in transplantable lymphoma cells by vinca alkaloids.
    Kotani M; Koizumi Y; Yamada T; Kawasaki A; Akabane T
    Cancer Res; 1978 Sep; 38(9):3094-9. PubMed ID: 209896
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of nitro-L-arginine on blood flow, oxygenation and the activity of hypoxic cell cytotoxins in murine tumours.
    Horsman MR; Chaplin DJ; Hill SA; Arnold S; Collingridge D; Radacic M; Wood PJ; Overgaard J
    Br J Cancer Suppl; 1996 Jul; 27():S168-71. PubMed ID: 8763873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical studies with the vinca alkaloids. I. Effect on nucleic acid formation by isolated cell suspensions.
    Richards JF; Jones RG; Beer CT
    Cancer Res; 1966 May; 26(5):876-81. PubMed ID: 5934799
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell kinetics after vincristine treatment of C3H/He spontaneous mammary tumors: implications for therapy.
    Braunschweiger PG; Schiffer LM
    J Natl Cancer Inst; 1978 May; 60(5):1043-8. PubMed ID: 642025
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytotoxicity of vinblastine and vincristine to pancreatic acinar cells.
    Nevalainen TJ
    Virchows Arch B Cell Pathol; 1975; 18(2):119-27. PubMed ID: 807028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifications in biochemical pathways produced by the Vinca alkaloids.
    Creasey WA
    Cancer Chemother Rep; 1968 Jun; 52(4):501-7. PubMed ID: 5743697
    [No Abstract]   [Full Text] [Related]  

  • 15. Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo.
    Horsman MR; Christensen KL; Overgaard J
    Int J Hyperthermia; 1989; 5(2):123-36. PubMed ID: 2926180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of microregional variations in tumor hypoxia following the administration of endostatin.
    Fenton BM; Paoni SF; Beauchamp BK; Tran B; Liang L; Grimwood B; Ding I
    Adv Exp Med Biol; 2003; 510():19-24. PubMed ID: 12580399
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppression of serum tumour necrosis factor-alpha by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acid.
    Browne WL; Wilson WR; Baguley BC; Ching LM
    Anticancer Res; 1998; 18(6A):4409-13. PubMed ID: 9891501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of micronucleated polychromatic erythrocyte (MN-PCE) induction in vivo by aneuploidogens.
    Morales-Ramírez P; Vallarino-Kelly T; Cruz-Vallejo V
    Mutat Res; 2004 Dec; 565(1):79-87. PubMed ID: 15576241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of tumour blood flow by vasoactive drugs: a role in cancer therapy.
    Chaplin DJ; Acker BD; Horsman MR
    Biomed Biochim Acta; 1989; 48(2-3):S264-8. PubMed ID: 2730621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical studies with the Vinca alkaloids.
    Richards JF
    Cancer Chemother Rep; 1968 Jun; 52(4):463-7. PubMed ID: 5743692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.